NL-OMON53280尚未招募4 期
Determination of tocilizumab trough levels during dose tapering in patients with rheumatoid arthritis (OPTIRA study) - OPTIRA study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- >=18 years of age - Diagnosed with rheumatoid arthritis and treated for it in
- •Franciscus Gasthuis and Vlietland - Treated with intravenous or subcutaneous
- •tocilizumab - Low disease activity for at least the last 6 months while using
- •tocilizumab with a current DAS28-ESR <=3.2. - Sufficient understanding of the
- •Dutch language.
排除标准
- 未提供
研究者
相似试验
招募中
4 期
Therapeutic drug monitoring in tocilizumab-treated rheumatoid arthritis patients: Pilot study of a double-blind randomised controlled trialrheuma10003816rheumatoid arthritisNL-OMON44574Amsterdam Rheumatology and immunology Center | Reade30
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5
招募中
2 期
Evaluation of the Effects of Tocilizumab Administration in Hospitalized COVID-19 PatientsIRCT20151227025726N29Iran University of Medical Sciences50
Unknown
4 期
Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid ArthritisTocilizumabRheumatoid ArthritisNCT03781310Tel-Aviv Sourasky Medical Center80
已完成
不适用
Extension of Tocilizumab Dose Intervals in Patients with Low to Moderate Disease Activity Rheumatoid Arthritis using IL-6 Serum Level as Starting Criteria.rheumatoid arthritisJPRN-UMIN000008404Japan Labour Health and Welfare Organization, Yokohama Rosai Hospital50